← Back to the list

PFIZER INC (PFE) revenue & profit

PFIZER INC (PFE): revenue $62.6B, net income $7.8B in 2025; latest quarter +2.6% year over year. From SEC filings.

$62.6BRevenue 2025
TickerPFE (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$62.6B
Net income 2025$7.8B
Net margin12.4%
Annual revenue growth-1.6%
Latest quarter (2026 Q2) · Revenue$15B
vs. same quarter last year+2.6%
Latest quarter · Net income-$248M

Annual revenue & net income

YearRevenueNet income
2022$101.2B
$31.4B
2023$59.6B
$2.1B
2024$63.6B
$8B
2025$62.6B
$7.8B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Pfizer, Team · Public domain · Wikimedia Commons

📷 Coolcaesar · CC BY-SA 4.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.

Related